These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9873746)

  • 21. Greater effects of fluoxetine and its combination with (-)-pindolol in elevating hypothalamic serotonin in rats during dark hours.
    Dreshfield LJ; Rocco VP; Wong DT
    Chin J Physiol; 1997 Jun; 40(2):57-61. PubMed ID: 9303241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychopharmacological profile of the selective serotonin reuptake inhibitor, paroxetine: implication of noradrenergic and serotonergic mechanisms.
    Redrobe JP; Bourin M; Colombel MC; Baker GB
    J Psychopharmacol; 1998; 12(4):348-55. PubMed ID: 10065908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potentiation by (-)Pindolol of the activation of postsynaptic 5-HT(1A) receptors induced by venlafaxine.
    Béïque JC; Blier P; de Montigny C; Debonnel G
    Neuropsychopharmacology; 2000 Sep; 23(3):294-306. PubMed ID: 10942853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies toward the discovery of the next generation of antidepressants. Part 2: incorporating a 5-HT(1A) antagonist component into a class of serotonin reuptake inhibitors.
    Mewshaw RE; Meagher KL; Zhou P; Zhou D; Shi X; Scerni R; Smith D; Schechter LE; Andree TH
    Bioorg Med Chem Lett; 2002 Feb; 12(3):307-10. PubMed ID: 11814784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and molecular modeling of new 1-aryl-3-[4-arylpiperazin-1-yl]-1-propane derivatives with high affinity at the serotonin transporter and at 5-HT(1A) receptors.
    Orús L; Pérez-Silanes S; Oficialdegui AM; Martínez-Esparza J; Del Castillo JC; Mourelle M; Langer T; Guccione S; Donzella G; Krovat EM; Poptodorov K; Lasheras B; Ballaz S; Hervías I; Tordera R; Del Río J; Monge A
    J Med Chem; 2002 Sep; 45(19):4128-39. PubMed ID: 12213056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of combined administration of 5-HT1A and/or 5-HT1B receptor antagonists and paroxetine or fluoxetine in the forced swimming test in rats.
    Tatarczyńska E; Kłodzińska A; Chojnacka-Wójcik E
    Pol J Pharmacol; 2002; 54(6):615-23. PubMed ID: 12866716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The augmentation hypothesis for improvement of antidepressant therapy: is pindolol a suitable candidate for testing the ability of 5HT1A receptor antagonists to enhance SSRI efficacy and onset latency?
    Kinney GG; Taber MT; Gribkoff VK
    Mol Neurobiol; 2000 Jun; 21(3):137-52. PubMed ID: 11379796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Interest of the use of pindolol in the treatment of depression: review].
    Brousse G; Schmitt A; Chereau I; Eschalier A; Dubray C; Llorca PM
    Encephale; 2003; 29(4 Pt 1):338-50. PubMed ID: 14615704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is the beneficial antidepressant effect of coadministration of pindolol really due to somatodendritic autoreceptor antagonism?
    Cremers TI; Wiersma LJ; Bosker FJ; den Boer JA; Westerink BH; Wikström HV
    Biol Psychiatry; 2001 Jul; 50(1):13-21. PubMed ID: 11457419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antagonist properties of (-)-pindolol and WAY 100635 at somatodendritic and postsynaptic 5-HT1A receptors in the rat brain.
    Corradetti R; Laaris N; Hanoun N; Laporte AM; Le Poul E; Hamon M; Lanfumey L
    Br J Pharmacol; 1998 Feb; 123(3):449-62. PubMed ID: 9504386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of sustained (+/-)pindolol administration on serotonin neurotransmission in rats.
    Haddjeri N; Blier P
    J Psychiatry Neurosci; 2000 Sep; 25(4):378-88. PubMed ID: 11022403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New 3-[4-(aryl)piperazin-1-yl]-1-(benzo[b]thiophen-3-yl)propane derivatives with dual action at 5-HT1A serotonin receptors and serotonin transporter as a new class of antidepressants.
    Martínez J; Pérez S; Oficialdegui AM; Heras B; Orús L; Villanueva H; Palop JA; Roca J; Mourelle M; Bosch A; Del Castillo JC; Lasheras B; Tordera R; del Río J; Monge A
    Eur J Med Chem; 2001 Jan; 36(1):55-61. PubMed ID: 11231049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects on sleep architecture of pindolol, paroxetine and their combination in healthy volunteers.
    Bell C; Wilson S; Rich A; Bailey J; Nutt D
    Psychopharmacology (Berl); 2003 Mar; 166(2):102-10. PubMed ID: 12536263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo microdialysis evidence for central serotonin1A and serotonin1B autoreceptor blocking properties of the beta adrenoceptor antagonist (-)penbutolol.
    Hjorth S; Sharp T
    J Pharmacol Exp Ther; 1993 May; 265(2):707-12. PubMed ID: 8098761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluoxetine attenuates thermal hyperalgesia through 5-HT1/2 receptors in streptozotocin-induced diabetic mice.
    Anjaneyulu M; Chopra K
    Eur J Pharmacol; 2004 Aug; 497(3):285-92. PubMed ID: 15336946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of different 5-HT1A receptor antagonists in combination with paroxetine on expression of the immediate-early gene Arc in rat brain.
    Tordera R; Pei Q; Newson M; Gray K; Sprakes M; Sharp T
    Neuropharmacology; 2003 Jun; 44(7):893-902. PubMed ID: 12726821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of pindolol to potentiate antidepressant medication.
    Blier P; Bergeron R
    J Clin Psychiatry; 1998; 59 Suppl 5():16-23; discussion 24-5. PubMed ID: 9635544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancement of fluoxetine-dependent increase of extracellular serotonin (5-HT) levels by (-)-pindolol, an antagonist at 5-HT1A receptors.
    Dreshfield LJ; Wong DT; Perry KW; Engleman EA
    Neurochem Res; 1996 May; 21(5):557-62. PubMed ID: 8726963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of venlafaxine on extracellular concentrations of 5-HT and noradrenaline in the rat frontal cortex: augmentation via 5-HT1A receptor antagonism.
    Dawson LA; Nguyen HQ; Geiger A
    Neuropharmacology; 1999 Aug; 38(8):1153-63. PubMed ID: 10462128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Repeated administration of milnacipran induces rapid desensitization of somatodendritic 5-HT1A autoreceptors but not postsynaptic 5-HT1A receptors.
    Mochizuki D; Hokonohara T; Kawasaki K; Miki N
    J Psychopharmacol; 2002 Sep; 16(3):253-60. PubMed ID: 12236634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.